In light of the adverse prognosis related to severe mitral regurgitation, heart failure, or
sudden cardiac death in a subset of patients with mitral valve prolapse (MVP), identifying …

Degenerative mitral regurgitation is a major threat to public health and affects at least 24
million people worldwide, with an estimated 0.88 million disability-adjusted life years and …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Background: The risk for and consequences of recurrent mitral regurgitation (MR) following
degenerative mitral valve repair are poorly understood. Objectives: This study sought to …

Objectives: We investigated whether global longitudinal strain (GLS) is a better predictor of
clinical events after surgery for mitral regurgitation (MR) than conventional parameters …

The “Guidelines for the clinical indications of echocardiography” of the Japanese Circulation
Society (JCS) were first developed between 1993 and 1994, and the first revision1 was …

Objective A proportion of patients experience a decrease in left ventricular (LV) ejection
fraction (EF) after mitral valve repair; however, predictors and long-term consequences …

Aims We sought to evaluate the impact of pulmonary hypertension on outcomes following
MitraClip therapy. Methods and results The 643 patients in the TRAnscatheter Mitral valve …